title: Tenofovir in the management of chronic hepatitis B infection during pregnancy.
abstract: Chronic hepatitis B infection has a worldwide distribution, with approximately 350 million infected persons. While become more of an issue during pregnancy concerning maternal and fetal well-being and the influence of pregnancy itself on the course of the disease; the natural history of chronic hepatitis B infection during pregnancy has not been clearly established. This paper reports the outcome of pregnancy in a patient with chronic hepatitis B infection who discontinued double antiviral treatment since she wanted to get pregnant but then was administered tenofovir disoproxil fumarate (TDF; 245 mg/day) monotherapy at the 32(nd) gestational week.
authors.affiliation: Clinic of Gastroenterology, Antalya Research and Training Hospital, Antalya, Turkey.
authors.forename: Ayhan Hilmi
authors.initials: AH
authors.lastname: Cekin
authors.affiliation: Clinic of Microbiology, Antalya Research and Training Hospital, Antalya, Turkey.
authors.forename: Yeşim
authors.initials: Y
authors.lastname: Cekin
keywords: Tenofovir; hepatitis B; pregnancy